tacrolimus
ACN-PRT-AD-12-1
Approved small_molecule completed
Quick answer
tacrolimus for Moderate/Severe Atopic Dermatitis is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Moderate/Severe Atopic Dermatitis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed